Abstract
The Alzheimer’s disease (AD) is a neurodegenerative disease, which is caused by the aggregation of beta-amyloid peptide (\(A\beta\)) in the patient’s brain and the disorder of \({\text{Ca}}^{2 + }\) homeostasis in neurons. Caluwé and Dupont (Theor Biol 331:12–18, 2013) proposed a deterministic AD model to explore the effect of \({\text{Ca}}^{2 + }\) on AD. They demonstrated the positive feedback loop between \(A\beta\) and \({\text{Ca}}^{2 + }:\) and the occurrence of bistability. Based on their results, we further discuss the bistable behaviors. We present two periodically feasible drug strategies to alleviate the AD and screen out more effective one. In this paper, we also formulate a stochastic AD model, analyze the existence and uniqueness of global positive solutions and establish sufficient conditions for the existence of ergodic stationary distribution. Furthermore, the confidence ellipses describing the configurational arrangement of stochastic coexistence equilibria are constructed by stochastic sensitivity function technique, and tipping threshold is estimated as well. Noise-induced stochastic switching between two coexistence equilibria is observed in bistability region. Our results provide a new idea to control noise to alleviate AD through physical therapy.
Similar content being viewed by others
Data availability
The manuscript has no associated data.
Notes
PrPC proteins: Cellular prion proteins. \(A\beta \)-x-PrPC: PrPC binds to \(A\beta \) oligomer as a receptor to produce \(A\beta \)-x-PrPC complex.
References
Caluwé, D.J., Dupont, G.: The progression towards Alzheimer’s disease described as a bistable switch arising from the positive loop between amyloids and Ca2+. J. Theor. Biol. 331, 12–18 (2013)
William, A., Markesbery, R.: Oxidative stress hypothesis in alzheimer’s disease. Free Radic. Biol. Med. 23(1), 134–147 (1997)
Ewen, S.T., Fauzi, A., Quan, T.Y., Chamyuang, S., Yin, A.: A review on advances of treatment modalities for Alzheimer’s disease. Life Sci. 276, 119129 (2021)
Reisberg, B., Ferris, S.H., De, L.M.J., Crook, T.: The global deterioration scale for assessment of primary degenerative dementia. Am. J. Psychiatry 139(9), 1136–1139 (1982)
Kang, Y.J., Diep, Y.N., Tran, M., Cho, H.: Therapeutic targeting strategies for early-to late-staged alzheimer’s disease. Int. J. Mol. Sci. 21(24), 1–34 (2020)
Zanetti, O., Solerte, S.B., Cantoni, F.: Life expectancy in Alzheimer’s disease (AD). Arch. Gerontol. Geriatr. 49, 237–243 (2009)
Hirtz, D.G., Thurman, D.J., Gwinn-Hardy, K., Mohamed, M., Zalutsky, R.: How common are the “common” neurologic disorders? Neurology 68(5), 326–337 (2007)
Wimo, A., Guerchet, M., Ali, G.C., Wu, Y.T., Matthew, A.: The worldwide costs of dementia 2015 and comparisons with 2010. Alzheimer’s Dement. 13(1), 1–7 (2017)
Hu, J., Zhang, Q., Meyer-Aese, A., Ye, M.: Stationary distribution of a stochastic Alzheimer’s disease model. Math. Method. Appl. Sci. 43(17), 1–13 (2020)
Sweeney, M.D., Kisler, K., Montagne, A., Toga, A.W., Zlokovic, B.V.: The role of brain vasculature in neurodegenerative disorders. Nat. Neurosci. 13, 18–31 (2018)
Ma, J.: Biophysical neurons, energy, and synapse controllability: a review. J. Zhejiang Univ. Sci. A 24(2), 109–129 (2023)
Li, H.X., Zhao, H.Y.: Mathematical model of Alzheimer’s disease with prion proteins interactions and treatment. Appl. Math. Comput. 433(15), 127377 (2022)
Dayeh, M.A., Livadiotis, G., Elaydi, S.: A discrete mathematical model for the aggregation of β-amyloid. PLoS ONE 13(5), e0196402 (2018)
Hu, J., Zhang, Q.M., Meyer-Baese, A., Ye, M.: Stability in distribution for a stochastic Alzheimer’s disease model with reaction diffusion. Nonlinear Dyn. 108, 4243–4260 (2022)
Helal, M., Hingant, E., Pujo-Menjouet, L., Webb, G.F.: Alzheimer’s disease: analysis of a mathematical model incorporating the role of prions. J. Math. Biol. 69(5), 1207–1235 (2014)
Hao, W., Friedman, A.: Mathematical model on Alzheimer’s disease. BMC Syst. Biol. 10(1), 108 (2016)
Asili, E., Yarahmadian, S., Khani, H., Sharify, M.: A mathematical model for amyloid-β aggregation in the presence of metal ions: a timescale analysis for the progress of alzheimer disease. Bull. Math. Biol. 81(6), 108 (2019)
Angelo, D., Erene, M., Kayed, R., Milton, S.C., Ian, P., Charles, G.G.: Calcium dysregulation and membrane disruption as a ubiquitous neurotoxic mechanism of soluble amyloid oligomers. J. Biol. Chem. 280(17), 17294–17300 (2005)
Kuchibhotla, K.V., Goldman, S.T., Lattarulo, C.R., Wu, H.Y., Hyman, B.T., Bacskai, B.J.: Aβ plaques lead to aberrant regulation of calcium homeostasis in vivo resulting in structural and functional disruption of neuronal networks. Neuron 59(2), 214–225 (2008)
Berridge, M.: Calcium signalling and Alzheimer’s disease. Neurochem. Res. 36(7), 1149–1156 (2011)
Ho, M., Hoke, D.E., Chua, Y.J., Li, Q.X., Culvenor, J.G., Masters, C., et al.: Effect of metal chelators on r-secretsindicates that calcium and magnesium ions facilitate cleavage of Alzheimer amyloid precursor substrate. Int. J. Alzheimers Dis. 2011(6106), 950932 (2010)
Dighe, S.N., Mora, E., Chan, S., Kantham, S., Ross, B.P.: Rivastigmine and metabolite analogues with putative Alzheimer’s disease-modifying properties in a caenorhabditis elegans model. Commun. Chem. 2(1), 1–13 (2019)
Pierrot, N., Ghisdal, P., Caumont, A., Jean, N.O.: Intraneuronal amyloid-β1-42 production triggered by sustained increase of cytosolic calcium concentration induces neuronal death. J. Neurochem. 88(5), 1140–1150 (2004)
Eugene, S., Xue, W.F., Robert, P., Doumic, M.: Insights into the variability of nucleated amyloid polymerization by a minimalistic model of stochastic protein assembly. J. Chem. Phys. 144(17), 175101 (2016)
Theriault, P., Elali, A., Rivest, S.: The dynamics of monocytes and microglia in Alzheimer’s disease. Alzheimers Res. Ther. 7(1), 1–10 (2015)
Falcke, M.: Reading the patterns in living cells-the physics of Ca2+ signaling. Adv. Phys. 53(3), 255–440 (2004)
Bashkirtseva, I., Ryazanova, T., Ryashko, L.: Confidence domains in the analysis of noise-induced transition to chaos for goodwin model of business cycles. Int. J. Bifurc. Chaos 24(8), 1–10 (2014)
Xu, C.Q., Yuan, S.L., Zhang, T.H.: Stochastic sensitivity analysis for a competitive turbidostat model with inhibitory nutrients. Int. J. Bifurc. Chaos 26(10), 1650173 (2016)
Xu, C.Q., Yuan, S.L., Zhang, T.H.: Sensitivity analysis and feedback control of noise-induced extinction for competition chemostat model with mutualism. Phys. A 505, 891–902 (2018)
Zhao, S.N., Yuan, S.L., Zhang, T.H.: The impact of environmental fluctuations on a plankton model with toxin-producing phytoplankton and patchy agglomeration. Chaos Solitons Fractal 162, 112426 (2020)
Alkhayuon, H., Tyson, R.C., Wieczorek, S.: Phase-sensitive tipping: how cyclic ecosystems respond to contemporary climate. Proc. R. Soc. A 477, 20210059 (2021)
Mattson, M.P., Bezprozvanny, I.: Neuronal calcium mishandling and the pathogenesis of Alzheimer’s disease. Trends Neurosci. 31(9), 454–463 (2008)
Bojarski, L., Herms, J., Kuznicki, J.: Calcium dysregulation in Alzheimer’s disease. Neurochem. Int. 52(4), 621–633 (2008)
Berridge, M.: Calcium hypothesis of Alzheimer’s disease. Eur. J. Physiol. 459(3), 441–449 (2010)
Rosa, A., Olaso-Gonzalez, G., Arc-Chagnaud, C., Millan, F., Salvador-Pascual, A.: Physical exercise in the prevention and treatment of Alzheimer’s disease. J. Sport Health Sci. 9(5), 394–404 (2020)
Li, X.X., Qi, G.Q., Yu, C., Lian, G.M., Zheng, H., Wu, S.C., et al.: Cortical plasticity is correlated with cognitive improvement in Alzheimer’s disease patients after rTMS treatment. Brain Stimul. 14(3), 503–510 (2021)
Tatiaparti, K., Sau, S., Rauf, M.A., Iyer, A.K.: Smart treatment strategies for alleviating tauopathy and neuroinflammation to improve clinical outcome in Alzheimer’s disease. Drug Discov. Today 25(12), 2110–2129 (2020)
Wang, Y.H., Xu, X.Y., Zhu, Y.T., Wang, R.B.: Neural energy mechanism and neurodynamics of memory transformation. Nonlinear Dyn. 97(1), 697–714 (2019)
Sun, X.J., Si, H.: Population rate coding in recurrent neuronal networks consisting of neurons with mixed excitatory–inhibitory synapses. Nonlinear Dyn. 100, 2673–2686 (2020)
Fleming, V., Piro-Gambetti, B., Patrick, A., Zammi, M., Alexander, A.: Physical activity and cognitive and imaging biomarkers of Alzheimer’s disease in down syndrome. Neurobiol. Aging 107, 118–127 (2021)
Higham, D.J.: An algorithmic introduction to numerical simulation of stochastic differential equations. SIAM Rev. 43(3), 525–546 (2001)
Mao, X.: Stochastic Differential Equations and Applications, 2nd edn. Woodhead, Cambridge (2008)
Hasminskii, R.Z.: Stochastic Stability of Differential Equations. Springer, Berlin (1980)
Gard, T.: Introduction to Stochastic Differential Equations. Marcel Dekker Inc., New York (1988)
Strang, G.: Linear Algebra and Its Applications. Thomson Learning Inc., Chicago (1988)
Zhu, C., Yin, G.: Asymptotic properties of hybrid diffusion systems. SIAM J. Control Optim. 46, 1155–1179 (2007)
Yuan, S., Wu, D., Lan, G., Wang, H.: Noise-induced transitions in a nonsmooth producer–grazer model with stoichiometric constraints. Bull. Math. Biol. 82(5), 55 (2020)
Zhang, S.Q., Yuan, S.L., Zhang, T.H.: A predator-prey model with different response functions to juvenile and adult prey in deterministic and stochastic environments. Appl. Math. Comput. 413, 126598 (2022)
Pallitto, M., Murphy, R.: A mathematical model of the kinetics of β-amyloid fibril growth from the denaturated state. Biophys. J. 81(3), 1805–1822 (2001)
Ortega, F., Stott, J., Visser, S., Bendtsen, C.: Interplay between α, β, and γ-secretases determines biphasic amyloid-β level in the presence of γ-secretases inhibitor. J. Biol. Chem. 288(2), 785–792 (2013)
Puri, I., Li, L.: Mathematical modeling for the pathogenesis of Alzheimer’s disease. PLoS ONE 5(12), e15176 (2010)
Murray, A., Faraoni, M., Castro, M., Alza, N., Cavallaro, V.: Natural AChE inhibitors from plants and their contribution to Alzheimer’s disease therapy. Curr. Neuropharmacol. 11(4), 388–413 (2013)
Rashid, T., Mithila, D., Safin, A., Ajit, G.: Advances on plant extracts and phytocompounds with acetylcholinesterase inhibition activity for possible treatment of Alzheimer’s disease. Phytomedicine Plus 2(1), 100184 (2021)
Srivastava, S., Ahmad, R., Khare, S.K.: Alzheimer’s disease and its treatment by different approaches: a review. Eur. J. Med. Chem. 216, 113320 (2021)
Zhang, H.Q., Zhao, Y.P., Yu, M., Zhao, Z.Q., Liu, P.X., Cheng, H., et al.: Reassembly of native components with donepezil to execute dual-missions in Alzheimer’s disease therapy. J. Control. Release 296, 14–28 (2019)
Assoc, A.: Alzheimer’s disease facts and figures. Alzheimers Dement. 14(3), 367–429 (2018)
Sperling, R.A., Aisen, P.S., Beckett, L.A.: Toward defining the preclinical stages of Alzheimer’s disease: recommendations from the national institute on aging-Alzheimer’s association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimers Dement. 7(3), 280–292 (2011)
Forsberg, A., Engler, H., Almkvist, O.: PET imaging of amyloid deposition in patients with mild cognitive impairment. Neurobiol. Aging 29(10), 1456–1465 (2008)
Palmqvist, S., Zetterberg, H., Mattsson, N.: Detailed comparison of amyloid PET and CSF biomarkers for identifying early Alzheimer disease. Neurology 85(14), 1240–1249 (2015)
Bigham, B., Zamanpour, S.A., Zare, H.: Features of the superficial white matter as biomarkers for the detection of Alzheimer’s disease and mild cognitive impairment: a diffusion tensor imaging study. Heliyon 8(1), e08725 (2022)
Owens, L.V., Benedetto, A., Dawson, N., Gaffney, C.J., Parkin, E.T.: Gene therapy-mediated enhancement of protective protein expression for the treatment of Alzheimer’s disease. Brain Res. 1753, 147264 (2021)
Achdou, Y., Franchi, B., Marcello, N., Tesi, M.C.: A qualitative model for aggregation and diffusion of β-amyloid in Alzheimer’s disease. J. Math. Biol. 67(6), 1369–1392 (2013)
Acknowledgments
We are grateful to two anonymous reviewers and the editor for their helpful comments.
Funding
This work was supported by NSERC Individual Discovery Grant (No. RGPIN-2020-03911), NSERC Discovery Accelerator Supplement Award (No. RGPAS-2020-00090), NSFC-Yunnan United fund (No. U2102221). JZG is partially supported by a CSC Doctoral Scholarship.
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Conflict of interest
All the authors declare that they have no conflict of interest.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Appendix
Appendix
From the second equation of the deterministic system (i.e., \(\sigma_{1} = \sigma_{2} = 0\) in (2)), we have
The bring (A.1) into the first equation of the deterministic system, we get a cubic equation in one variable with respect to \(x\)
where
We assume that (A.2) has three positive equilibria, \(x_{1} ,x_{2}\) and \(x_{3}\) (\(x_{1} < x_{2} < x_{3}\)). \(F^{\prime } (x_{1} )\) is the derivative of \(F(x)\) at \(x_{i}\). We can easily get that \(F^{\prime } (x_{1} ) < 0\), \(F^{\prime } (x_{2} ) > 0\) and \(F^{\prime } (x_{3} ) < 0\). Next, we give the stability analysis of the equilibria.
Calculate the Jacobian matrix \(J(E_{i} )\) of the deterministic system at internal equilibrium \(E_{i} (x_{i} ,y_{i} )\)
The eigenvalues of \(J(E_{i} )\) satisfy the equation:
where,
because \(F^{\prime } (x_{1} ) < 0\), \(F^{\prime } (x_{2} ) > 0\) and \(F^{\prime } (x_{3} ) < 0\), so \(E_{1}\) and \(E_{3}\) are asymptotically stable and \(E_{2}\) is an unstable saddle point.
In addition, the two equations on the right of the deterministic system are respectively defined as \(H_{1}\) and \(H_{2}\), then
According to the Bendixson–Dulac criteria, it is clear that there is no closed orbit in the deterministic system, that is, when the deterministic system has a unique equilibrium, it must be globally asymptotically stable.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Gao, J., Ji, J., Liu, Y. et al. A confidence ellipse analysis for stochastic dynamics model of Alzheimer's disease. Nonlinear Dyn 111, 13513–13533 (2023). https://doi.org/10.1007/s11071-023-08547-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11071-023-08547-y